Skip to main content
. 2023 Jan 31;29(12):1886–1894. doi: 10.1093/ibd/izad001

Table 5.

Distribution of misdiagnoses according to health care level by sex.

Global Women Men P OR; 95% CI
Emergency department
 Misdiagnosis in global IBD 66/120 (55) 39/59 (66.1) 27/61 (44.3) 0.016* 2.4; 1.1-5.1
 Misdiagnosis in CD 46/69 (66.7) 29/38 (76.3) 17/31 (54.8) 0.060 2.6; 0.94-7.4
 Misdiagnosis in UC 20/51 (39.2) 10/21 (47.6) 10/30 (33.3) 0.304 1.8; 0.57-5.7
Primary care
 Misdiagnosis in global IBD 89/166 (53.6) 54/83 (65.1) 35/83 (42.2) 0.003* 2.5; 1.3-4.7
 Misdiagnosis in CD 52/87 (59.8) 34/50 (68) 18/37 (48.6) 0.069 2.2; 0.9-5.3
 Misdiagnosis in UC 37/79 (46.8) 20/33 (60.6) 17/46 (37) 0.038* 2.6; 1.04-6.5
Secondary care
 Misdiagnosis in global IBD 29/130 (22.3) 19/65 (29.2) 10/65 (15.4) 0.058 2.2; 0.96-5.3
 Misdiagnosis in CD 19/72 (26.4) 13/43 (30.2) 6/29 (20.7) 0.368 1.6; 0.54-5
 Misdiagnosis in UC 10/58 (17.2) 6/22 (27.3) 4/36 (11.1) 0.156 3; 0.74-12.1
Hospitalization
 Misdiagnosis in global IBD 14/84 (16.7) 11/43 (25.6) 3/41 (7.3) 0.025* 4.3; 1.1-16.9
 Misdiagnosis in CD 12/52 (23.1) 9/31 (29) 3/21 (14.3) 0.216 2.4; 0.57-10.4
 Misdiagnosis in UC 2/32 (6.3) 2/12 (16.7) 0/20 (0) 0.133 NA

Values are n/N (%). Abbreviations: OR, odds ratio; CI, confidence interval; IBD, irritable bowel disease; CD, Crohn’s disease; UC, ulcerative colitis; NA, not calculable.

*statistically significant at P < .05.